METHOD OF AND SYSTEM FOR OBESITY TREATMENT USING LAPAROSCOPICALLY-GUIDED 3D-STEREOSCOPIC AND IR-THERMOGRAPHIC INTRA-ABDOMINAL VISCERAL FAT ASPIRATION, SUPPORTED BY REAL-TIME CYTOKINE SENSING AND PROFILING AND AUGMENTED-REALITY (AR) DISPLAY AND VISUAL SAMPLE TAGGING

Smart overview of the Invention

A novel method and system for treating obesity, metabolic syndrome, and Type II diabetes involves a 3D-stereoscopic IR-thermographic intra-abdominal visceral fat aspiration system. This system utilizes a powered fat aspiration instrument, which can be operated by a surgeon or surgical robot. It includes a specialized twin-cannula assembly designed for safely removing visceral fat from the mesenteric region through small incisions, while also enabling real-time cytokine sensing and profiling.

Background and State of Knowledge

Previous patents have laid the groundwork for safe outpatient removal of visceral fat, highlighting the importance of targeting metabolically active fat deposits. Techniques involving twin-cannula instruments with RF electro-cautery have demonstrated effectiveness in this area. However, there remains a significant need for improved speed and feedback mechanisms during fat tissue analysis to enhance treatment outcomes for patients suffering from metabolic syndrome and Type II diabetes.

Cytokine Profiling in Obesity Treatment

Cytokines are critical in mediating immune responses and are linked to obesity and metabolic disorders. Profiling these proteins can offer insights into disease progression and treatment efficacy. The proposed system aims to incorporate advanced detection techniques for cytokines, utilizing various scientific disciplines to enhance clinical testing capabilities, thus improving treatment strategies for patients with obesity-related conditions.

Objectives of the Invention

• To provide a safe method for removing mesenteric fat to alleviate chronic conditions like metabolic syndrome.
• To utilize 3D-stereoscopic imaging and augmented reality for guided visceral fat aspiration.
• To enhance real-time cytokine profiling during surgical procedures.
• To develop an efficient laparoscopic system that minimizes patient risk associated with traditional surgical methods.

Potential Health Benefits

The proposed method aims to improve metabolic health by selectively removing visceral fat, which is known to negatively impact insulin sensitivity and contribute to various metabolic disorders. By addressing these factors, the system seeks to lower blood sugar levels, improve lipid profiles, and ultimately reduce the risk of coronary artery disease associated with obesity. The integration of advanced technology promises a more effective approach to treating Type II diabetes and related conditions.